Atomo Diagnostics Limited

ASX:AT1 Stock Report

Market Cap: AU$12.8m

Atomo Diagnostics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Atomo Diagnostics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Jul 05
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Oct 10
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth

Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

Jun 10
Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?

We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Dec 06
We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn

Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

Nov 01
Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate

We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Jul 19
We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow

Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Feb 26
Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)

Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Jan 22
Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business

Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

Dec 18
Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like

When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

Jul 16
When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Atomo Diagnostics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:AT1 - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20244-7-5-5N/A
3/31/20244-7-5-5N/A
12/31/20233-7-5-5N/A
9/30/20233-9-6-6N/A
6/30/20233-10-6-6N/A
3/31/20235-9-5-4N/A
12/31/20228-9-4-3N/A
9/30/202210-7-4-3N/A
6/30/202212-6-5-3N/A
3/31/202210-6-8-5N/A
12/31/20217-6-12-6N/A
9/30/20217-6-11-5N/A
6/30/20217-6-10-4N/A
3/31/20218-8-9-4N/A
12/31/20209-10-8-4N/A
9/30/20207-9-8-5N/A
6/30/20205-9-8-6N/A
3/31/20203-7-6-4N/A
12/31/20191-5-4-3N/A
9/30/20191-5-3-2N/A
6/30/20191-5-3-2N/A
6/30/20180-5-6-6N/A
6/30/20170-5N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AT1's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if AT1's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if AT1's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AT1's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if AT1's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AT1's Return on Equity is forecast to be high in 3 years time


Discover growth companies